BCR and cancer: In contrast, the median BCR-free survival time was similar between the ISUP/Gleason grade <7 and ≥7 groups [99 (91, 113) months and 97 (89, 107) months, respectively] (log rank P = 0.373) and cancer stage I/II and III/IV groups [98 (90, 109) months and 96 (88, 108) months respectively] (log rank P = 0.014) (Fig. 2B, C).